5 insiders reported 71 Form 4 transactions for BioXcel Therapeutics, Inc. (BTAI) over the past 18 months (most recent 2026-06-17). Recent activity: Steinhart Richard I (Chief Financial Officer) Buy 35 shares, Yocca Frank (Chief Scientific Officer) Buy 35 shares, Mehta Vimal (CEO and President) Buy 219 shares, Rodriguez Javier (See Remarks) Buy 35 shares, Steinhart Richard I (Chief Financial Officer) Buy 17,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Steinhart Richard I | Chief Financial Officer | Buy | 35 | $0 |
| 2026-06-17 | Yocca Frank | Chief Scientific Officer | Buy | 35 | $0 |
| 2026-06-17 | Mehta Vimal | CEO and President | Buy | 219 | $0 |
| 2026-06-17 | Rodriguez Javier | See Remarks | Buy | 35 | $0 |
| 2026-05-22 | Steinhart Richard I | Chief Financial Officer | Buy | 17,500 | $0 |
| 2026-05-22 | Yocca Frank | Chief Scientific Officer | Buy | 17,500 | $0 |
| 2026-05-22 | Mehta Vimal | CEO and President | Buy | 49,758 | $0 |
| 2026-05-22 | Rodriguez Javier | See Remarks | Buy | 17,500 | $0 |
| 2026-05-22 | Steinhart Richard I | Chief Financial Officer | Sell | 6,845 | $7,427 |
| 2026-05-22 | Yocca Frank | Chief Scientific Officer | Sell | 6,845 | $7,427 |
| 2026-05-22 | Mehta Vimal | CEO and President | Sell | 19,419 | $21,108 |
| 2026-05-22 | Rodriguez Javier | See Remarks | Sell | 6,560 | $7,111 |
| 2026-05-07 | Yocca Frank | Chief Scientific Officer | Buy | 9,000 | $0 |
| 2026-05-07 | Mehta Vimal | CEO and President | Buy | 18,000 | $0 |
| 2026-05-07 | Rodriguez Javier | See Remarks | Buy | 9,000 | $0 |
| 2026-05-07 | Steinhart Richard I | Chief Financial Officer | Buy | 9,000 | $0 |
| 2026-03-16 | Steinhart Richard I | Chief Financial Officer | Buy | 33 | $0 |
| 2026-03-16 | Steinhart Richard I | Chief Financial Officer | Buy | 35 | $0 |
| 2026-03-16 | Yocca Frank | Chief Scientific Officer | Buy | 33 | $0 |
| 2026-03-16 | Yocca Frank | Chief Scientific Officer | Buy | 35 | $0 |
| 2026-03-16 | Mehta Vimal | CEO and President | Buy | 164 | $0 |
| 2026-03-16 | Mehta Vimal | CEO and President | Buy | 219 | $0 |
| 2026-03-16 | Rodriguez Javier | See Remarks | Buy | 33 | $0 |
| 2026-03-16 | Rodriguez Javier | See Remarks | Buy | 35 | $0 |
| 2025-12-15 | Steinhart Richard I | Chief Financial Officer | Buy | 33 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17